(Q39465207)

12 September 2017

1 reference

title

Eradication of Helicobacter pylori infection (English)

1 reference

eradication of infectious diseases

12 September 2017

0 references

1 reference

based on heuristic

inferred from title

Helicobacter pylori infectious disease

1 reference

R H Hunt

1

1 reference

12 September 2017

language of work or name

English

0 references

publication date

1 May 1996

1 reference

American Journal of Medicine

12 September 2017

published in

1 reference

12 September 2017

volume

100

1 reference

12 September 2017

issue

5A

1 reference

12 September 2017

page(s)

42S-50S; discussion 50S-51S

1 reference

Cure of duodenal ulcer associated with eradication of Helicobacter pylori

12 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2980228-2

Cost-effectiveness of Helicobacter pylori eradication for the long-term management of duodenal ulcer in Canada

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2980228-2

'Cure' of Helicobacter pylori. Clinically indicated and economically wise!

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2980228-2

Treatment of Helicobacter pylori reduces the rate of rebleeding in peptic ulcer disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2980228-2

Role of Helicobacter pylori eradication in the prevention of peptic ulcer bleeding relapse

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2980228-2

Eradication of Helicobacter pylori reduces the possibility of rebleeding in peptic ulcer disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2980228-2

Helicobacter pylori eradication reduces the rate of rebleeding in ulcer hemorrhage

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2980228-2

High prevalence of Helicobacter pylori metronidazole resistance in migrants to east London: relation with previous nitroimidazole exposure and gastroduodenal disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2980228-2

Randomised controlled trial of short term treatment to eradicate Helicobacter pylori in patients with duodenal ulcer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2980228-2

Effect of triple therapy (antibiotics plus bismuth) on duodenal ulcer healing. A randomized controlled trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2980228-2

Effect of ranitidine and amoxicillin plus metronidazole on the eradication of Helicobacter pylori and the recurrence of duodenal ulcer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2980228-2

Long-term follow-up after eradication of Helicobacter pylori with a combination of omeprazole and amoxycillin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2980228-2

Amoxycillin capsules with omeprazole for the eradication of Helicobacter pylori. Assessment of the importance of antibiotic dose timing in relation to meals

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2980228-2

Effect of omeprazole on concentrations of clarithromycin in plasma and gastric tissue at steady state

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2980228-2

Effect of omeprazole on the distribution of antibiotics in gastric juice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2980228-2

Eradication of Helicobacter pylori with lansoprazole and clarithromycin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2980228-2

Effect of acid suppression on efficacy of treatment for Helicobacter pylori infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2980228-2

Potent inhibitory action of the gastric proton pump inhibitor lansoprazole against urease activity of Helicobacter pylori: unique action selective for H. pylori cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2980228-2

Is there an optimal degree of acid suppression for healing of duodenal ulcers? A model of the relationship between ulcer healing and acid suppression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2980228-2

Secretion of intravenously administered antibiotics in gastric juice: implications for management of Helicobacter pylori

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2980228-2

Inhibitory antimicrobial concentrations against Campylobacter pylori in gastric mucosa

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2980228-2

A critique of therapeutic trials in Helicobacter pylori-positive functional dyspepsia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2980228-2

Review article: Helicobacter pylori eradication--understandable caution but no excuse for inertia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2980228-2

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0002-9343(96)80228-2

1 reference

12 September 2017

1 reference